Herbalife (NYSE:HLF) Downgraded to "Buy" Rating by Wall Street Zen

Key Points

• Herbalife's rating was downgraded from a "strong-buy" to a "buy" by Wall Street Zen.
• Mizuho raised its price target on Herbalife shares from $8.00 to $9.00, maintaining a "neutral" rating.
• Despite recent lower revenue, Herbalife reported an earnings per share (EPS) of $0.59, surpassing the consensus estimate.

Herbalife (NYSE:HLF - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a report issued on Sunday.

Separately, Mizuho upped their price objective on shares of Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a research note on Monday, July 28th. Three research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $11.50.

Herbalife Stock Performance

Shares of NYSE HLF opened at $8.86 on Friday. The firm has a market capitalization of $913.76 million, a P/E ratio of 2.80, a PEG ratio of 0.27 and a beta of 0.89. Herbalife has a one year low of $5.04 and a one year high of $10.83. The company's fifty day moving average is $9.42 and its two-hundred day moving average is $8.40.

Herbalife (NYSE:HLF - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.53 by $0.06. Herbalife had a net margin of 6.59% and a negative return on equity of 27.36%. The business had revenue of $1.26 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same period in the previous year, the firm earned $0.54 EPS. The business's revenue for the quarter was down 1.7% compared to the same quarter last year. On average, sell-side analysts forecast that Herbalife will post 1.57 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Herbalife

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in shares of Herbalife by 10.9% during the 1st quarter. Vanguard Group Inc. now owns 12,495,374 shares of the company's stock worth $107,835,000 after purchasing an additional 1,223,957 shares in the last quarter. Long Focus Capital Management LLC raised its stake in shares of Herbalife by 3.9% during the 1st quarter. Long Focus Capital Management LLC now owns 4,943,000 shares of the company's stock worth $42,658,000 after purchasing an additional 184,873 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Herbalife by 13.4% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,057,219 shares of the company's stock worth $26,384,000 after purchasing an additional 360,659 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Herbalife by 1.1% during the 2nd quarter. Geode Capital Management LLC now owns 2,810,794 shares of the company's stock worth $24,231,000 after purchasing an additional 31,077 shares in the last quarter. Finally, Iridian Asset Management LLC CT raised its stake in shares of Herbalife by 10.7% during the 1st quarter. Iridian Asset Management LLC CT now owns 2,775,430 shares of the company's stock worth $23,952,000 after purchasing an additional 267,690 shares in the last quarter.

Herbalife Company Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.